Ads
related to: receptor tyrosine kinase
Search results
Kala Pharma Stops Working On Certain Preclinical Programs, Extends Cash Runway Into 2024
Benzinga via Yahoo Finance· 2 years agoKala Pharmaceuticals Inc (NASDAQ: KALA) said it would focus its efforts on KPI-012, mesenchymal stem...
BMS and Zai Lab’s Augtyro gains NMPA approval to treat NSCLC
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoZai Lab has announced that its New Drug Application (NDA) for Augtyro (repotrectinib) has been...
Spectrum's (SPPI) NDA for NSCLC Candidate Gets CRL From FDA
Zacks via Yahoo Finance· 2 years agoSpectrum Pharmaceuticals, Inc. SPPI announced that the company has received a Complete Response...
Psychedelic drugs to treat depression without causing hallucinations may finally be near
The Independent via Yahoo News· 12 months agoScientists have found psychedelic drugs LSD and psilocin bind to a specific receptor in the brain to...
KRAS inhibitors: The next frontier beckons
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoAlthough KRAS and its links to cancer were discovered decades ago, the characteristics of its protein structure were thought to make it “undruggable”....
Merck (MRK) Keytruda Studies in Difficult-to-Treat Cancers Fail
Zacks via Yahoo Finance· 1 year agoMerck (MRK) and Eisai announce the discontinuation of the phase III LEAP-003 study seeking approval...
AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence
InvestorPlace via Yahoo Finance· 7 months agoWe’re still in the initial stages of a massively disruptive artificial intelligence (AI) boom. Big...
3 Under-the-Radar Biotech Stocks to Buy in 2023
Motley Fool· 9 months agoMost people have either had cancer themselves or know someone who has. According to the American Cancer Society, 1 in 3 people in the U.S. will be...
2 Biotech Stocks That Could Make You Richer
Motley Fool· 11 months agoVoyager Therapeutics (NASDAQ: VYGR) and Zymeworks (NYSE: ZYME) are far from household names, but the two clinical-stage biotech companies could fairly be...
Analysts Say These 2 Stocks Are Their ‘Top Picks’ for the Rest of 2023
TipRanks via Yahoo Finance· 11 months agoAnyone involved in the investing game will know it’s all about ‘stock picking.’ Choosing the right...
